Claudiu Morgovan

1.4k total citations · 2 hit papers
53 papers, 947 citations indexed

About

Claudiu Morgovan is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Claudiu Morgovan has authored 53 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Claudiu Morgovan's work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Diabetes Treatment and Management (4 papers) and Skin Protection and Aging (3 papers). Claudiu Morgovan is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (4 papers), Diabetes Treatment and Management (4 papers) and Skin Protection and Aging (3 papers). Claudiu Morgovan collaborates with scholars based in Romania, France and Italy. Claudiu Morgovan's co-authors include Luca Liviu Rus, Anca Maria Juncan, Andreea Loredana Vonica-Țincu, Felicia Gabriela Gligor, Carmen Maximiliana Dobrea, Anca Maria Arseniu, Adina Frum, Adriana Aurelia Chiş, Anca Butucă and Felicia Loghin and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Nutrients.

In The Last Decade

Claudiu Morgovan

49 papers receiving 921 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Applications and Limitations of Dendrimers in Biomedicine

2020 296 citations Adriana Aurelia Chiş, Carmen Maximiliana Dobrea et al. Molecules profile →
Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals

2021 213 citations Anca Maria Juncan, Claudiu Morgovan et al. Molecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudiu Morgovan Romania	16	224	164	123	93	93	53	947
Luca Liviu Rus Romania	13	210 0.9×	164 1.0×	131 1.1×	96 1.0×	94 1.0×	36	848
Anca Maria Juncan Romania	9	171 0.8×	157 1.0×	114 0.9×	100 1.1×	92 1.0×	25	651
Payam Khazaeli Iran	20	169 0.8×	198 1.2×	129 1.0×	51 0.5×	33 0.4×	63	1.1k
Joon Seok Bang South Korea	14	320 1.4×	443 2.7×	202 1.6×	50 0.5×	48 0.5×	63	1.2k
Himanshu Agrawal India	13	251 1.1×	269 1.6×	186 1.5×	74 0.8×	55 0.6×	34	919
Gholamhossein Yousefi Iran	17	244 1.1×	235 1.4×	148 1.2×	52 0.6×	27 0.3×	46	895
Deepak Pradhan India	16	170 0.8×	183 1.1×	127 1.0×	59 0.6×	21 0.2×	78	1.0k
Ching‐Yun Hsu Taiwan	23	477 2.1×	83 0.5×	144 1.2×	55 0.6×	19 0.2×	56	1.4k
Chih-Hung Lin Taiwan	18	325 1.5×	122 0.7×	137 1.1×	181 1.9×	29 0.3×	37	1.3k
Takehisa Hanawa Japan	17	181 0.8×	206 1.3×	97 0.8×	18 0.2×	80 0.9×	91	1.0k

Countries citing papers authored by Claudiu Morgovan

Since Specialization

Citations

This map shows the geographic impact of Claudiu Morgovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudiu Morgovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudiu Morgovan more than expected).

Fields of papers citing papers by Claudiu Morgovan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudiu Morgovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudiu Morgovan. The network helps show where Claudiu Morgovan may publish in the future.

Co-authorship network of co-authors of Claudiu Morgovan

This figure shows the co-authorship network connecting the top 25 collaborators of Claudiu Morgovan. A scholar is included among the top collaborators of Claudiu Morgovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudiu Morgovan. Claudiu Morgovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arseniu, Anca Maria, Cristina Trandafirescu, Cristian Oancea, et al.. (2025). Comparative Analysis of Neuropsychiatric Adverse Reactions Associated with Remdesivir and Nirmatrelvir/Ritonavir in COVID-19 Treatment: Insights from EudraVigilance Data. Journal of Clinical Medicine. 14(6). 1886–1886. 1 indexed citations

Dobrea, Carmen Maximiliana, Anca Butucă, Adina Frum, et al.. (2025). Exploring the Cardiovascular Safety Profile of Ibuprofen: Insights from EudraVigilance Database. Pharmaceuticals. 18(7). 1045–1045.

Butucă, Anca, Claudiu Morgovan, Adina Frum, et al.. (2025). Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment. Pharmaceuticals. 18(4). 501–501. 1 indexed citations

Dobrea, Carmen Maximiliana, Claudiu Morgovan, Adina Frum, et al.. (2025). The Assessment of the Safety Profile of Selective Serotonin Reuptake Inhibitors Versus Other Antidepressants: Drug–Drug Interaction Insights from EudraVigilance. Journal of Clinical Medicine. 14(4). 1208–1208. 1 indexed citations

Ilie, Ioana, Anca Butucă, Călin Homorodean, et al.. (2025). Osilodrostat Safety Profile: Findings from Real-World Data in the FAERS Database. Journal of Clinical Medicine. 14(10). 3518–3518.

Dobrea, Carmen Maximiliana, Anca Butucă, Adina Frum, et al.. (2025). Pharmacovigilance Insights into Ibuprofen’s Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports. Pharmaceuticals. 18(9). 1301–1301.

Ilie, Ioana, Carmen Maximiliana Dobrea, Anca Butucă, et al.. (2024). Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance. Pharmaceuticals. 17(12). 1631–1631. 3 indexed citations

Dobrea, Carmen Maximiliana, Adina Frum, Anca Butucă, et al.. (2024). Drug–Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database. Pharmaceuticals. 17(10). 1278–1278. 2 indexed citations

Morgovan, Claudiu, Carmen Maximiliana Dobrea, Anca Butucă, et al.. (2024). Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance. Biomedicines. 12(5). 953–953. 7 indexed citations

10.

Butucă, Anca, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.. (2024). Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies. Viruses. 16(12). 1811–1811. 3 indexed citations

11.

Chiş, Adriana Aurelia, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.. (2024). Antibody–Drug Conjugates—Evolution and Perspectives. International Journal of Molecular Sciences. 25(13). 6969–6969. 17 indexed citations

12.

Arseniu, Anca Maria, Claudiu Morgovan, Anca Butucă, et al.. (2024). A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection. Antibiotics. 13(2). 144–144. 14 indexed citations

13.

Butucă, Anca, Andreea Loredana Vonica-Țincu, Claudiu Morgovan, et al.. (2024). The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity. Cancers. 16(22). 3847–3847. 5 indexed citations

14.

Chiş, Adriana Aurelia, Paula Sfîrloagă, Gerlinde Rusu, et al.. (2023). Some Brassicaceae Extracts as Potential Antioxidants and Green Corrosion Inhibitors. Materials. 16(8). 2967–2967. 8 indexed citations

15.

Arseniu, Anca Maria, Anca Butucă, Victoria Bîrluțiu, et al.. (2023). Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database. Antibiotics. 12(5). 918–918. 17 indexed citations

16.

Chiş, Adriana Aurelia, Anca Maria Arseniu, Claudiu Morgovan, et al.. (2022). Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics. 14(9). 1773–1773. 15 indexed citations

17.

Farcaș, Andreea, et al.. (2022). Post-Marketing Surveillance of Statins—A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance. Pharmaceuticals. 15(12). 1536–1536. 19 indexed citations

18.

Rus, Luca Liviu, Anca Maria Juncan, Adina Frum, et al.. (2022). Determination of Zn2+ in Solid Pharmaceutical Dosage Forms by Means of Spectrophotometry in Micellar Media: Method Validation. Applied Sciences. 12(9). 4476–4476. 2 indexed citations

19.

Chiş, Adriana Aurelia, Carmen Maximiliana Dobrea, Luca Liviu Rus, et al.. (2021). Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy. Molecules. 26(19). 5976–5976. 16 indexed citations

20.

Morgovan, Claudiu, Smaranda Cosma, Anca Maria Juncan, et al.. (2020). An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System. International Journal of Environmental Research and Public Health. 17(12). 4456–4456. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact